JP2016513680A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513680A5
JP2016513680A5 JP2016502332A JP2016502332A JP2016513680A5 JP 2016513680 A5 JP2016513680 A5 JP 2016513680A5 JP 2016502332 A JP2016502332 A JP 2016502332A JP 2016502332 A JP2016502332 A JP 2016502332A JP 2016513680 A5 JP2016513680 A5 JP 2016513680A5
Authority
JP
Japan
Prior art keywords
item
month
gelatin capsule
soft gelatin
storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502332A
Other languages
English (en)
Japanese (ja)
Other versions
JP6335269B2 (ja
JP2016513680A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/027093 external-priority patent/WO2014152226A1/en
Publication of JP2016513680A publication Critical patent/JP2016513680A/ja
Publication of JP2016513680A5 publication Critical patent/JP2016513680A5/ja
Application granted granted Critical
Publication of JP6335269B2 publication Critical patent/JP6335269B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502332A 2013-03-15 2014-03-14 医薬ソフトゼラチンカプセル剤形 Active JP6335269B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361794813P 2013-03-15 2013-03-15
US61/794,813 2013-03-15
PCT/US2014/027093 WO2014152226A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form

Publications (3)

Publication Number Publication Date
JP2016513680A JP2016513680A (ja) 2016-05-16
JP2016513680A5 true JP2016513680A5 (enExample) 2017-04-13
JP6335269B2 JP6335269B2 (ja) 2018-05-30

Family

ID=50391548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502332A Active JP6335269B2 (ja) 2013-03-15 2014-03-14 医薬ソフトゼラチンカプセル剤形

Country Status (11)

Country Link
US (1) US20140271837A1 (enExample)
EP (1) EP2968183B1 (enExample)
JP (1) JP6335269B2 (enExample)
CN (1) CN105392476B (enExample)
AU (1) AU2014240039B2 (enExample)
CA (1) CA2906619C (enExample)
ES (1) ES2681982T3 (enExample)
HK (1) HK1220113A1 (enExample)
IL (1) IL242438B (enExample)
MX (1) MX376951B (enExample)
WO (1) WO2014152226A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3031628B2 (ja) 1990-04-07 2000-04-10 株式会社日立製作所 洗濯乾燥機
JP3143355B2 (ja) 1995-03-28 2001-03-07 三洋電機株式会社 遠心脱水装置
US10673198B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-coupled laser with time varying beam characteristics
US10673199B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based saturable absorber
US10673197B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based optical modulator
IL302889A (en) * 2020-11-13 2023-07-01 Pfizer Talazoparib soft gelatin capsule dosage form

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US5102666A (en) * 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
AU1925697A (en) 1996-03-12 1997-10-01 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
CN1906207A (zh) 2004-01-15 2007-01-31 沃纳奇尔科特公司 乙炔雌二醇的二-甾族前体药物
WO2005070949A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
CN101237851B (zh) 2005-06-16 2013-09-18 沃纳奇尔科特有限责任公司 用于阴道给药的雌激素组合物
EP1910401A2 (en) 2005-07-12 2008-04-16 Warner Chilcott Company, Inc. 3-ester prodrugs of ethynylestradiol
US20070015741A1 (en) 2005-07-12 2007-01-18 James Keown Novel prodrugs of estradiol
JP5406530B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス, インコーポレイテッド 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
US20070104778A1 (en) * 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
EP2011496A1 (en) * 2007-07-03 2009-01-07 Indena S.P.A. Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions

Similar Documents

Publication Publication Date Title
GT201600142A (es) Composiciones farmacéuticas que comprenden azd9291
JP2016513680A5 (enExample)
JP2015078230A5 (enExample)
HUE061174T2 (hu) 1,3,4-oxadiazol-szulfonamid-származék vegyületek mint hiszton-deacetiláz-6 inhibitorok, és az ilyen vegyületeket tartalmazó gyógyszerkészímény
JP2013523835A5 (enExample)
JP2016535100A5 (enExample)
AR128816A2 (es) Formas de dosificación farmacéutica de perlas de cisteamina
IL247653A0 (en) Pharmaceutical compositions and benzoic acid salts of 4,2,1-oxadiazole
ECSP17044282A (es) Formulación de relación fija de insulina glargina/lixisenatida
CL2014002524A1 (es) Composicion farmaceutica que comprende un compuesto activo de formula 1, antagonista de ccr3, dos diluyentes, un aglutinante, un desintegrante y un lubricante; formas de dosificacion en capsula, comprimido o comprimido recubierto con pelicula.
CO2017005544A2 (es) Tableta multicapa que contiene fármaco inestable a la luz
SI3316867T1 (sl) Tablete s takojšnjim sproščanjem, ki vsebujejo zdravilo in postopek za pripravo tablet
HUE041914T2 (hu) Gyógyászati készítmények és alkalmazások lizoszomális tárolási rendellenességekhez
IL242438B (en) Dosage form soft pharmaceutical gelatin capsule
IL241377A0 (en) Dosage form soft pharmaceutical gelatin capsule with modified guar resin
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
HUE042932T2 (hu) Koleszterinészter-transzferprotein (CETP) inhibitor és az említett inhibitort tartalmazó gyógyászati készítmény szív- és érrendszeri betegségek kezelésében vagy megelõzésében való alkalmazásra
JP2014529579A5 (enExample)
PH12016502272A1 (en) Ceritinib formulation
CL2016000182A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
HRP20220749T1 (hr) Sastav koji sadrži apoaequorin za upotrebu u postupku liječenja smrti živčanih stanica od ishemije oralnom primjenom
DK3153163T3 (da) Farmaceutisk forbindelse der omfatter 13 glycerider, formulering og anvendelse deraf
WO2015114655A3 (en) Modified release tablet of pregabalin
徐欢 It's a Small World
HUE049403T2 (hu) Temozolomide tartalmú stabil antineoplasztikus gyógyszerkészítmény és eljárás a készítmény elõállítására